Page 97 - Sohini Das

Multiplexes' revenue may be hit by up to 25% amid coronavirus spread

According to sources, the box office collections of Angr­ezi Medium dropped by 25% on Saturday.

Spike in viewership across OTTs as Indians binge-watch staying indoors

Viewership on OTT platforms has gone up by 20% in the past few days as corporates have offered employees to work from home

Govt bans exports of masks and ventilator machines amid coronavirus spread

Exporters who have delivery commitments would face a challenge as a result

Social distancing amid virus pushes patients to consult doctors online

Digital healthcare platform Practo, for example, has seen a jump of three to four times in requests for consultation with general physicians

Govt plans five large coronavirus-dedicated hospitals as cases rise

The government was looking to have large, at least four or five, dedicated COVID19 hospitals in the country to isolate and treat the patients

Doctors to hand wash: Why India isn't ready for coronavirus crisis

Country fares worse than the top affected nations in key medical infrastructure and health care investments

Zydus Wellness gets a Complan boost, Sourav Ganguly's star power for brands

Over a year since the company acquired Complan, Glucon-D and Nycil, it is redrawing the marketing formula around its newly acquired brands

Multiplex chains on overdrive to add screens next financial year

Leading multiplex chain owner PVR Cinemas, which opened 83 screens during 2019-20, has now set a target of 120-130 screens for the next FY

Malls, multiplexes bear the brunt of coronavirus outbreak ahead of Holi

Holi will be celebrated on Tuesday across India. The four-day weekend starting Saturday would have come as a boon for retailers, malls and multiplex operators

From Baaghi 3 to Sooryavanshi, big Bollywood films face coronavirus heat

Film events such as IIFA 2020 have been postponed for now

Coronavirus panic, it's catching: What companies and individuals are doing

While businesses have taken a hit, the crisis has also uncovered a human side to the cold and abstract face of globalisation

Music streaming app Gaana aims to be operationally profitable in 3 years

The platform, which has a 45 million strong library, now has 152 million monthly active users

Coronavirus impact: Firms stare at prospect of airlifting raw materials

Pharma industry officials said the aerial route was the best option available to companies right now, given the congestion at Chinese ports.

Will double turnover with anti-diabetic bet, says Boehringer Ingelheim

Boehringer has expanded its field force to 570 representatives to boost their diabetes medicine sales that contributes nearly 75 per cent of the company's turnover

USFDA warnings: Concerns remain even as India fares better than US

According to the USFDA, India accounted for nearly 18 per cent of the active pharmaceutical ingredients (APIs) sourced by the US, while China accounted for 13 per cent

Coronavirus outbreak: Don't panic over supplies, says pharma industry

Sun Pharma's Dilip Shanghvi said the industry and government were working closely to reduce dependence on one country

NPPA allows differential price for Meril's biodegradable cardiac stent

The National Pharmaceutical Pricing Authority (NPPA) invoked the para 32 (ii) of the Drug Price Control Order, 2013 to grant the exemption to the indigenously developed stent

True North scouts for acquisitions in orthopaedics and gynaecology space

Now, True North is focussed on growing Integrace by buying other products, divisions or smaller companies. Integrace is clocking a 12-15 per cent growth

Govt sanctions Rs 1,850 cr to ensure better drug monitoring systems

A significant share of this money will go into upgrading the Sugam portal - the e-governance solution for CDSCO.

India scores better than US in regulatory action by USFDA in 2019

From FY15 to FY19, Indian manufacturers received fewer warning letters than Chinese counterparts